188 related articles for article (PubMed ID: 23033840)
1. Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients.
Reinhard H; Garde E; Skimminge A; Åkeson P; Ramsøy TZ; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2012 Oct; 11():119. PubMed ID: 23033840
[TBL] [Abstract][Full Text] [Related]
2. NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients.
Reinhard H; Hansen PR; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2012 Mar; 11():19. PubMed ID: 22390472
[TBL] [Abstract][Full Text] [Related]
3. Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate.
Reinhard H; Hansen PR; Persson F; Tarnow L; Wiinberg N; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Nephrol Dial Transplant; 2011 Oct; 26(10):3242-9. PubMed ID: 21372253
[TBL] [Abstract][Full Text] [Related]
4. NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis.
Reinhard H; Wiinberg N; Hansen PR; Kjær A; Petersen CL; Winther K; Parving HH; Rossing P; Jacobsen PK
Cardiovasc Diabetol; 2011 Aug; 10():71. PubMed ID: 21812947
[TBL] [Abstract][Full Text] [Related]
5. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
[TBL] [Abstract][Full Text] [Related]
6. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.
Hamano K; Nakadaira I; Suzuki J; Gonai M
Vasc Health Risk Manag; 2014; 10():585-9. PubMed ID: 25328404
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
[TBL] [Abstract][Full Text] [Related]
8. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study.
Ballo P; Betti I; Barchielli A; Balzi D; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
Clin Res Cardiol; 2016 May; 105(5):421-31. PubMed ID: 26547915
[TBL] [Abstract][Full Text] [Related]
10. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study.
Mishra RK; Judson G; Christenson RH; DeFilippi C; Wu AHB; Whooley MA
Cardiology; 2017; 137(4):201-206. PubMed ID: 28445886
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and Carotid Markers Link With Accelerated Brain Atrophy: The AGES-Reykjavik Study (Age, Gene/Environment Susceptibility-Reykjavik).
Sabayan B; van Buchem MA; Sigurdsson S; Zhang Q; Meirelles O; Harris TB; Gudnason V; Arai AE; Launer LJ
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2246-2251. PubMed ID: 27609370
[TBL] [Abstract][Full Text] [Related]
12. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria.
Hamano K; Abe M; Komi R; Kobayashi S
Diabetes Metab Res Rev; 2010 Oct; 26(7):534-9. PubMed ID: 20812386
[TBL] [Abstract][Full Text] [Related]
13. Cross-Sectional Associations Between Cardiac Biomarkers, Cognitive Performance, and Structural Brain Changes Are Modified by Age.
Veugen MGJ; Henry RMA; Brunner-La Rocca HP; Dagnelie PC; Schram MT; van Agtmaal MJM; van der Kallen CJH; Sep SJS; van Boxtel MPJ; Bekers O; Meex SJR; Jansen JFA; Kroon AA; Stehouwer CDA
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1948-1958. PubMed ID: 29954754
[TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
15. Association of NT-proBNP and multiple biomarkers with severity of angiographic coronary artery disease in diabetic and pre-diabetic Chinese patients.
Fang Z; Zhou L; Bao Y; Ding W; Shi H; Luo X; Hu R
PLoS One; 2011; 6(8):e22563. PubMed ID: 21857933
[TBL] [Abstract][Full Text] [Related]
16. The Clinical Value of N-Terminal Pro B-Type Natriuretic Peptide in Evaluating Obstructive Sleep Apnea in Patients With Coronary Artery Disease.
Liu Y; Huang Z; Huang K; Li G; Luo J; Xu Y; Chen P; Chen J; Wang L
J Clin Sleep Med; 2019 Oct; 15(10):1403-1409. PubMed ID: 31596204
[TBL] [Abstract][Full Text] [Related]
17. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
18. NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk.
Klein Hesselink EN; van der Horst-Schrivers ANA; van der Horst ICC; Bakker SJL; Muller Kobold AC; Brouwers AH; de Bock GH; Gietema JA; Dullaart RPF; Links TP; Lefrandt JD
Clin Biochem; 2017 Aug; 50(12):696-702. PubMed ID: 28242284
[TBL] [Abstract][Full Text] [Related]
19. N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease.
Tuñón J; Higueras J; Tarín N; Cristóbal C; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Huelmos A; Alonso J; Aceña Á; Pello A; Carda R; Asensio D; Mahíllo-Fernández I; López Bescós L; Egido J; Farré J
PLoS One; 2015; 10(6):e0126741. PubMed ID: 26046344
[TBL] [Abstract][Full Text] [Related]
20. Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial.
Jarolim P; White WB; Cannon CP; Gao Q; Morrow DA
Diabetes Care; 2018 Jul; 41(7):1510-1515. PubMed ID: 29848776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]